Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal–bolus treatment in people with Type 1 diabetes: 1–year results from a randomized clinical trial (BOOST (®) T1)

AIMS: To evaluate the long‐term safety and efficacy of a simplified basal–bolus regimen of once‐daily insulin degludec/insulin aspart (IDegAsp) with additional IAsp vs. a standard basal–bolus insulin regimen of insulin detemir (IDet) with IAsp in adults with Type 1 diabetes. METHODS: This was an ope...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabet Med
Main Authors: Hirsch, I. B., Franek, E., Mersebach, H., Bardtrum, L., Hermansen, K.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248618/
https://ncbi.nlm.nih.gov/pubmed/26773446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13068
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados